Eikonizo Therapeutics, a biopharmaceutical company dedicated to developing disease-modifying therapies to improve the lives of people impacted by neurodegenerative and cardiorenal diseases announced ...
The global blood and bone marrow cancer drug market size was US$ 39.1 billion in 2021. The global blood and bone marrow cancer drug market is forecast to grow to US$ 79.8 billion by 2030 by ...